SDC1 and diabetic peripheral angiopathy: Though studies showed HS mimetics/HPSE inhibitors (heparin, PI-88, SST001, etc.)fortify Sdc1 content of vascular endothelial cells and prevent the progression of diabetic angiopathy 39,40, there are few studies investigating whether they protect against HG-induced gastrointestinal damage.